María Isabel Peralta-Ramírez

María Isabel Peralta-Ramírez

Auto-generated profile, based on publicly available information

María Isabel Peralta-Ramírez

Mind, Brain, and Behavior Research Center (CIMCYC), University of Granada, 18071 Granada, Spain

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Physiology & Behavior
Verified
Journal Article
Closed access
MGMaría Ángeles García-León
María Ángeles García-León
JPJosé Manuel Pérez-Mármol
José Manuel Pérez-Mármol
RGRaquel Gonzalez-Pérez
Raquel Gonzalez-Pérez
MGMaría del Carmen García-Ríos
María del Carmen García-Ríos
MPMaría Isabel Peralta-Ramírez
María Isabel Peralta-Ramírez

28 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RCRafael A. Caparros-Gonzalez
Rafael A. Caparros-Gonzalez
BRBorja Romero-Gonzalez
Borja Romero-Gonzalez
HSHelen Strivens-Vilchez
Helen Strivens-Vilchez
RGRaquel Gonzalez-Perez
Raquel Gonzalez-Perez
OMOlga Martinez-Augustin
Olga Martinez-Augustin
MPMaria Isabel Peralta-Ramirez
Maria Isabel Peralta-Ramirez
Postpartum depression affects a huge number of women and has detrimental consequences. Knowing the factors associated with postpartum depression during pregnancy can help its prevention. Although there is evidence surrounding behavioral or psychological predictors of postpartum depression, there is a lack of evidence of biological forecasters. The aim of this study was to analyze the sociodemographic, obstetric, and psychological variables along with hair cortisol levels during the first, second, and third trimesters of pregnancy that could predict postpartum depression symptoms. A sample of 44 pregnant women was assessed during 3 trimesters of pregnancy and the postpartum period using psychological questionnaires and hair cortisol levels. Participants were divided into 2 groups: a group with postpartum depression symptoms and a group with no postpartum depression symptoms. Results showed significant positive differences between groups in the first trimester regarding the Somatization subscale of the SCL-90-R (p < .05). In the second trimester, significant differences were found in the Somatization, Depression, Anxiety, and GSI subscales (p < .05). In the third trimester significant differences between both groups were found regarding pregnancy-specific stress. We found significant positive differences between groups regarding hair cortisol levels in the first and the third trimester. Hair cortisol levels could predict 21.7% of the variance of postpartum depression symptoms. In conclusion, our study provided evidence that psychopathological symptoms, pregnancy-specific stress, and hair cortisol levels can predict postpartum depression symptoms at different time-points during pregnancy. These findings can be applied in future studies and improve maternal care in clinical settings.

1 September 2018 in International Journal of Psychophysiology
Verified
Journal Article
Closed access
EMEva Montero-López
Eva Montero-López
ASAna Santos-Ruiz
Ana Santos-Ruiz
MGMaría del Carmen García-Ríos
María del Carmen García-Ríos
MRManuel Rodríguez-Blázquez
Manuel Rodríguez-Blázquez
HRHeather L. Rogers
Heather L. Rogers
MPMaría Isabel Peralta-Ramírez
María Isabel Peralta-Ramírez

6 July 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BRBorja Romero-Gonzalez
Borja Romero-Gonzalez
RCRafael A Caparros-Gonzalez
Rafael A Caparros-Gonzalez
RGRaquel Gonzalez-Perez
Raquel Gonzalez-Perez
PDPilar Delgado-Puertas
Pilar Delgado-Puertas
MPMaria Isabel Peralta-Ramirez
Maria Isabel Peralta-Ramirez
Cortisol obtained from hair samples represents a retrospective biomarker of chronic stress experienced by the subject in previous months. Although hair cortisol levels have been used to study the relationship between maternal and neonatal stress levels in primates, this has not yet been performed in humans using a longitudinal design and focusing specifically on this association. Therefore, the objective of this study was to determine whether a relationship existed between maternal psychological stress and hair cortisol levels during pregnancy and postpartum, and neonatal hair cortisol levels. The sample consisted of 80 pregnant women and their 80 newborn infants. We conducted a longitudinal assessment of hair cortisol levels, psychological stress, anxiety, and depression in the three trimesters of pregnancy and postpartum. After childbirth, neonatal hair cortisol levels were also measured. We found that maternal hair cortisol levels in the first trimester negatively predicted neonatal hair cortisol levels. Perceived stress in the third trimester of pregnancy also predicted lower neonatal cortisol, whereas pregnancy-specific stress in the same trimester had a positive relation with neonatal cortisol. Cortisol is essential for embryonic and fetal development; consequently, if fetal synthesis of cortisol is affected by high maternal cortisol levels, such development could be impaired.

1 May 2005 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
FAFrancisco Aguilar de Arcos
Francisco Aguilar de Arcos
AVAntonio Verdejo-Garcia
Antonio Verdejo-Garcia
MPMaría Isabel Peralta-Ramírez
María Isabel Peralta-Ramírez
MSMaría Sánchez-Barrera
María Sánchez-Barrera
MPMiguel Perez-Garcia
Miguel Perez-Garcia

20 January 2010 in Psychotherapy and Psychosomatics
Verified
Journal Article
Closed access
NNN. Navarrete-Navarrete
N. Navarrete-Navarrete
MPM.I. Peralta-Ramírez
M.I. Peralta-Ramírez
JSJ.M. Sabio-Sánchez
J.M. Sabio-Sánchez
MCM.A. Coín
M.A. Coín
HRH. Robles-Ortega
H. Robles-Ortega
JJJ. Jiménez-Alonso
J. Jiménez-Alonso
Background: Chronic stress worsens the quality of life (QOL) of lupus patients by affecting their physical and psychological status. The effectiveness of a cognitive-behavioural intervention in a group of patients with lupus and high levels of daily stress was investigated. Methods: Forty-five patients with lupus and high levels of daily stress were randomly assigned to a control group (CG) or a therapy group (TG); they received cognitive behavioural therapy (CBT) which consisted of ten consecutive weekly sessions. The following variables were evaluated at baseline and at 3, 9 and 15 months: (1) stress, anxiety, depression, (2) Systemic Lupus Erythematosus Disease Activity Index, somatic symptoms, number of flares, (3) anti-nDNA antibodies, complement fractions C3 and C4 and (4) QOL. A multivariate analysis of repeated measures and various analyses of variance were carried out. Results: We found a significant reduction in the level of depression, anxiety and daily stress in the TG compared to the CG and a significant improvement in QOL and somatic symptoms in the TG throughout the entire follow-up period. We did not find any significant changes in the immunological parameters. Conclusions: CBT is effective in dealing with patients suffering from lupus and high levels of daily stress as it significantly reduces the incidence of psychological disorders associated with lupus and improves and maintains patients’ QOL, despite there being no significant reduction in the disease activity index.